Christopher J Miller MD Dermatology

Penn Medicine, located in Philadelphia, PA, stands as a pillar of academic medical excellence with a strong commitment to patient well-being, education, and cutting-edge research initiatives. As an integral part of the University of Pennsylvania, this institution offers a wide array of healthcare services, spanning from routine primary care to specialized treatments in fields such as cardiology, oncology, neurology, and surgical interventions. Emphasizing a culture of teamwork and knowledge-sharing, Penn Medicine fosters collaboration among medical professionals, researchers, and educators to drive continuous advancements in medical practices and therapies. Through a network of hospitals, outpatient centers, and research facilities, this establishment is dedicated to elevating the standards of patient-focused healthcare and pushing the boundaries of scientific exploration. Generated using this brand's available information

Jared M Weiss MD is an adjunct assistant professor of medicine specializing in hematology-oncology at the University of Pennsylvania in Philadelphia, PA. He has a particular interest in the evaluation and management of patients with multiple myeloma, AL amyloidosis, and Waldenstrom's macroglobulinemia, as well as other paraprotein-associated diseases. Dr. Weiss is actively involved in clinical, translational, and epidemiologic research in plasma cell disorders, with a primary focus on myeloma precursor states and the development of novel biomarkers for progression in these conditions. Dr. Weiss is also the leader of the multi-disciplinary Penn Amyloidosis Program, which brings together clinicians from various disciplines to provide comprehensive care for patients with amyloidosis. With a strong background in research and clinical expertise, Dr. Weiss is dedicated to advancing the understanding and treatment of plasma cell disorders, contributing to the development of new diagnostic criteria and participating in trials of novel agents for AL amyloidosis and relapsed and refractory multiple myeloma.Generated from the website